Haynes:MamCultureMedia: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
| (10 intermediate revisions by 2 users not shown) | |||
| Line 16: | Line 16: | ||
| SK-N-SH (adherent) || Eagle's Minimum Essential Medium (EMEM) || 10% FBS, 1% pen/strep | | SK-N-SH (adherent) || Eagle's Minimum Essential Medium (EMEM) || 10% FBS, 1% pen/strep | ||
|- | |- | ||
| | | U-2 OS (adherent) || McCoy's 5A || 10% FBS, 1% pen/strep | ||
|- | |||
| MCF7 (adherent) || Eagle's Minimum Essential Medium (EMEM) || 10% FBS, 1% pen/strep, 0.01 mg/mL human recombinant insulin | |||
|- | |||
| BT-474 (adherent<sup>1</sup>) || ATCC Hybri-Care Medium<sup>2</sup> || 10% FBS, 1% pen/strep, 1.5 g/L sodium bicarbonate | |||
|- | |||
| BT-549 (adherent) || ATCC RPMI-1640 Medium || 10% FBS, 1% pen/strep, 0.0008 mg/mL human recombinant insulin | |||
|} | |} | ||
<sup>1</sup> BT-474 cells form adherent patches of epithelial-like cells. The patches are compact multilayered colonies that rarely become confluent.<br> | |||
<sup>2</sup> Hybri-Care Medium is a powder that needs to be dissolved in water before use. | |||
<br> | <br> | ||
| Line 26: | Line 36: | ||
| '''Cell Type''' || '''Genotype''' || '''Transfected Plasmid''' || '''Medium''' || '''Supplements<br>(required)''' || '''Selection<br>antibiotic(s)''' | | '''Cell Type''' || '''Genotype''' || '''Transfected Plasmid''' || '''Medium''' || '''Supplements<br>(required)''' || '''Selection<br>antibiotic(s)''' | ||
|- | |- | ||
| U2OS (adherent) || Flp-in T-REx || pcDNA5/FRT, or V0200 || McCoy's 5A || 10% FBS, 1 % pen/strep || 15 ug/mL blasticidin, 200 μg/mL | | U2OS (adherent) || Flp-in T-REx || pcDNA5/FRT, or V0200 || McCoy's 5A || 10% FBS-tf, 1 % pen/strep || 15 ug/mL blasticidin, 200 μg/mL hygromycin | ||
|- | |||
| U2OS (adherent) || misc. || MV2 or pcDNA3.1/puro || McCoy's 5A || 10% FBS-tf, 1 % pen/strep || 15 ug/mL blasticidin, 1.0 μg/mL puromycin | |||
|} | |} | ||
| Line 36: | Line 48: | ||
| '''Cell Type''' || '''Genotype''' || '''Medium''' || '''Supplements<br>(required)''' || '''Maintenance<br>antibiotic(s)''' | | '''Cell Type''' || '''Genotype''' || '''Medium''' || '''Supplements<br>(required)''' || '''Maintenance<br>antibiotic(s)''' | ||
|- | |- | ||
| U2OS (adherent) || Flp-in T-REx, untransfected || McCoy's 5A || 10% FBS, 1 % pen/strep || 100 ug/mL Zeocin, 15 ug/mL blasticidin | | U2OS (adherent) || Flp-in T-REx, untransfected || McCoy's 5A || 10% FBS-tf, 1 % pen/strep || 100 ug/mL Zeocin, 15 ug/mL blasticidin | ||
|- | |||
| U2OS (adherent) || Flp-in T-REx, hygro-transfected || McCoy's 5A || 10% FBS-tf, 1 % pen/strep || 15 ug/mL blasticidin, 60 μg/mL hygromycin | |||
|- | |- | ||
| U2OS (adherent) || Flp-in T-REx, | | U2OS (adherent) || Flp-in T-REx, puro-transfected || McCoy's 5A || 10% FBS-tf, 1 % pen/strep || 15 ug/mL blasticidin, 0.5 μg/mL puromycin | ||
|- | |- | ||
| HEK 293 (adherent) || Flp-in T-REx || DMEM, high glucose || 10% FBS, 1 % pen/strep || 100 ug/mL Zeocin, 15 ug/mL blasticidin | | HEK 293 (adherent) || Flp-in T-REx || DMEM, high glucose || 10% FBS-tf, 1 % pen/strep || 100 ug/mL Zeocin, 15 ug/mL blasticidin | ||
|- | |- | ||
| HEK 293 (adherent) || luc Gal4-EED "23;4;9" (K. Hansen) || DMEM, high glucose || 10% FBS, 1 % pen/strep || 0.5 ug/mL puromycin | | HEK 293 (adherent) || luc Gal4-EED "23;4;9" (K. Hansen) || DMEM, high glucose || 10% FBS-tf, 1 % pen/strep || 0.5 ug/mL puromycin | ||
|} | |} | ||
| Line 52: | Line 66: | ||
* FBS-tf = tetracycline-free FBS (required to maintain the "off" state of dox-inducible transgenes) | * FBS-tf = tetracycline-free FBS (required to maintain the "off" state of dox-inducible transgenes) | ||
* pen/strep = penicillin and streptomycin anti fungal supplement | * pen/strep = penicillin and streptomycin anti fungal supplement | ||
* Filter sterilize all media before use | * Filter-sterilize all media before use | ||
* Store all media at 4°C | * Store all media at 4°C | ||
</div> | </div> | ||
Revision as of 13:19, 15 June 2015
Mammalian Culture Media
"Wild type" stock cells (non-transgenic)
| Cell line | Incomplete media | Supplements for complete media (required) |
| HEK293 (adherent) | DMEM, high glucose | 10% FBS, 1% pen/strep |
| K-562 (suspension) | Iscove's Modified Dulbecco's Medium (IMDM) | 10% FBS, 1% pen/strep |
| SK-N-SH (adherent) | Eagle's Minimum Essential Medium (EMEM) | 10% FBS, 1% pen/strep |
| U-2 OS (adherent) | McCoy's 5A | 10% FBS, 1% pen/strep |
| MCF7 (adherent) | Eagle's Minimum Essential Medium (EMEM) | 10% FBS, 1% pen/strep, 0.01 mg/mL human recombinant insulin |
| BT-474 (adherent1) | ATCC Hybri-Care Medium2 | 10% FBS, 1% pen/strep, 1.5 g/L sodium bicarbonate |
| BT-549 (adherent) | ATCC RPMI-1640 Medium | 10% FBS, 1% pen/strep, 0.0008 mg/mL human recombinant insulin |
1 BT-474 cells form adherent patches of epithelial-like cells. The patches are compact multilayered colonies that rarely become confluent.
2 Hybri-Care Medium is a powder that needs to be dissolved in water before use.
Transgenic Cell Selection
| Cell Type | Genotype | Transfected Plasmid | Medium | Supplements (required) |
Selection antibiotic(s) |
| U2OS (adherent) | Flp-in T-REx | pcDNA5/FRT, or V0200 | McCoy's 5A | 10% FBS-tf, 1 % pen/strep | 15 ug/mL blasticidin, 200 μg/mL hygromycin |
| U2OS (adherent) | misc. | MV2 or pcDNA3.1/puro | McCoy's 5A | 10% FBS-tf, 1 % pen/strep | 15 ug/mL blasticidin, 1.0 μg/mL puromycin |
Transgenic Cell Maintenance
| Cell Type | Genotype | Medium | Supplements (required) |
Maintenance antibiotic(s) |
| U2OS (adherent) | Flp-in T-REx, untransfected | McCoy's 5A | 10% FBS-tf, 1 % pen/strep | 100 ug/mL Zeocin, 15 ug/mL blasticidin |
| U2OS (adherent) | Flp-in T-REx, hygro-transfected | McCoy's 5A | 10% FBS-tf, 1 % pen/strep | 15 ug/mL blasticidin, 60 μg/mL hygromycin |
| U2OS (adherent) | Flp-in T-REx, puro-transfected | McCoy's 5A | 10% FBS-tf, 1 % pen/strep | 15 ug/mL blasticidin, 0.5 μg/mL puromycin |
| HEK 293 (adherent) | Flp-in T-REx | DMEM, high glucose | 10% FBS-tf, 1 % pen/strep | 100 ug/mL Zeocin, 15 ug/mL blasticidin |
| HEK 293 (adherent) | luc Gal4-EED "23;4;9" (K. Hansen) | DMEM, high glucose | 10% FBS-tf, 1 % pen/strep | 0.5 ug/mL puromycin |
Notes
- FBS = fetal bovine serum
- FBS-tf = tetracycline-free FBS (required to maintain the "off" state of dox-inducible transgenes)
- pen/strep = penicillin and streptomycin anti fungal supplement
- Filter-sterilize all media before use
- Store all media at 4°C
